Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E R Pearson

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|September 6, 2000
Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetesE R Pearson, W G Liddell, M Shepherd, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 16, 2010
Increased all-cause and cardiovascular mortality in monogenic diabetes as a result of mutations in the HNF1A geneA M Steele, B M Shields, M Shepherd, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 26, 2015
Organic cation transporter 1 variants and gastrointestinal side effects of metformin in patients with Type 2 diabetesT Dujic, A Causevic, T Bego, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 26, 2015
Recessive mutations in the cancer gene Ataxia Telangiectasia Mutated (ATM), at a locus previously associated with metformin response, cause dysglycaemia and insulin resistanceP J Connelly, N Smith, R Chadwick, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 26, 2006
The effect of obesity on glycaemic response to metformin or sulphonylureas in Type 2 diabetesL A Donnelly, A S F Doney, A T Hattersley, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 24, 2004
Serum amino acids in patients with mutations in the hepatocyte nuclear factor-1 alpha geneA Stride, E R Pearson, A Brown, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 13, 2013
The utility of retinal screening in gestational diabetesD P Macfarlane, E P O'Sullivan, S Dorman, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 25, 2005
Preserved insulin response to tolbutamide in hepatocyte nuclear factor-1alpha mutation carriersJ V Sagen, E R Pearson, A Johansen, et al.
Diabetes|March 29, 2001
beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutationsE R Pearson, G Velho, P Clark, et al.
Diabetologia|April 13, 2007
TCF7L2 in the Go-DARTS study: evidence for a gene dose effect on both diabetes susceptibility and control of glucose levelsC H Kimber, A S F Doney, E R Pearson, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Diabetic Medicine : a Journal of the British Diabetic Association|September 6, 2000
Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetesE R Pearson, W G Liddell, M Shepherd, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 16, 2010
Increased all-cause and cardiovascular mortality in monogenic diabetes as a result of mutations in the HNF1A geneA M Steele, B M Shields, M Shepherd, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 26, 2015
Organic cation transporter 1 variants and gastrointestinal side effects of metformin in patients with Type 2 diabetesT Dujic, A Causevic, T Bego, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 26, 2015
Recessive mutations in the cancer gene Ataxia Telangiectasia Mutated (ATM), at a locus previously associated with metformin response, cause dysglycaemia and insulin resistanceP J Connelly, N Smith, R Chadwick, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 26, 2006
The effect of obesity on glycaemic response to metformin or sulphonylureas in Type 2 diabetesL A Donnelly, A S F Doney, A T Hattersley, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 24, 2004
Serum amino acids in patients with mutations in the hepatocyte nuclear factor-1 alpha geneA Stride, E R Pearson, A Brown, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 13, 2013
The utility of retinal screening in gestational diabetesD P Macfarlane, E P O'Sullivan, S Dorman, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 25, 2005
Preserved insulin response to tolbutamide in hepatocyte nuclear factor-1alpha mutation carriersJ V Sagen, E R Pearson, A Johansen, et al.
Diabetes|March 29, 2001
beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutationsE R Pearson, G Velho, P Clark, et al.
Diabetologia|April 13, 2007
TCF7L2 in the Go-DARTS study: evidence for a gene dose effect on both diabetes susceptibility and control of glucose levelsC H Kimber, A S F Doney, E R Pearson, et al.
Pageof 3